4.8 • 3.6K Ratings
🗓️ 10 November 2022
⏱️ 13 minutes
🧾️ Download transcript
Click on a timestamp to play from that location
0:00.0 | You may have heard the expression knowledge is power. |
0:03.6 | Well, today we're going to give you more power to control your diet and lifestyle by giving you |
0:09.7 | the facts. Welcome to the Nutrition Facts Podcast. I'm your host, Dr. Michael Greger. |
0:16.7 | Did you know that most chemotherapy drugs are approved by the FDA without evidence of |
0:22.4 | benefit unsurvival or quality of life? Here's our first story. Over the next few decades, |
0:28.8 | the number of new cancer cases will continue to skyrocket. Are we winning the war on cancer? |
0:36.6 | Sadly, in general, no. This, despite the introduction of hundreds of new anti-cancer drugs, |
0:42.9 | the war on cancer has been likened to the war on terror. No matter how many drone strikes you do, |
0:48.5 | it's nearly impossible to kill all the bad guys. No matter how precise the bombing, one must always |
0:53.7 | consider the collateral damage. The toxicity from cancer therapy can be debilitating and not |
1:00.3 | just health-wise. There's also the financial toxicity. Patented anti-cancer drugs are priced at |
1:08.0 | up to nearly $1,000 a day. Even with health insurance, the average cost of patients for stage 4 |
1:15.0 | breast cancer, for example, can run $190,000. It's bad enough to be fighting for your life without |
1:22.7 | bankrupting your family at the same time. I promise, still comment to this day. |
1:29.4 | Who can forget the apocryphal story of Walter White working two jobs with health insurance and |
1:35.3 | still could not afford the cancer care? No, not everyone is willing to start their own |
1:41.5 | meth lab, but many are willing to go for broke. A large proportion of cancer patients reported |
1:47.2 | their willingness to declare bankruptcy or sell their homes to pay for treatment. I mean, look, |
1:52.8 | I mean, aren't the high prices justified if new and innovative treatments offer significant |
1:57.6 | benefits to patients? But you may be shocked to find out that many FDA-approved cancer drugs may |
2:05.6 | lack clinical benefit. Well, then how did they become FDA approved? Most approvals of cancer |
2:14.8 | drugs are based on flimsy or untested surrogate endpoints and post-marketing studies rarely validate |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from [email protected], and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of [email protected] and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2025.